EcoDrugPlus

Adrenoceptor Alpha 1b

Ensembl ID : ENSCCRG00000052745
Gene Symbol: ADRA1B
1 Cross references
191 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSCCRG00000058798
Gene Symbol: ADRA1B
1 Cross references
191 Possible Orthologues:

Adrenoceptor Alpha 1bb

Ensembl ID : ENSCCRG00000043054
Gene Symbol: ADRA1BB
1 Cross references
189 Possible Orthologues:

Adrenoceptor Alpha 1bb

Ensembl ID : ENSCCRG00000050301
Gene Symbol: ADRA1BB
1 Cross references
189 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSCCRG00000063398
Gene Symbol: ADRA1D
1 Cross references
191 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSCCRG00000027198
Gene Symbol: ADRA1D
1 Cross references
192 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSCCRG00000057501
Gene Symbol: ADRA2A
1 Cross references
173 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSCCRG00000058284
Gene Symbol: ADRA2A
1 Cross references
173 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSCCRG00000069849
Gene Symbol: ADRA2B
1 Cross references
208 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSCCRG00000076304
Gene Symbol: ADRA2B
1 Cross references
208 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSCCRG00000065027
Gene Symbol: ADRA2C
1 Cross references
159 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSCCRG00000000657
Gene Symbol: ADRA2C
1 Cross references
158 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).